期刊文献+

文拉法辛与阿米替林、氟西汀治疗抑郁症的对照研究 被引量:2

The Control Study between Venlafaxine and Amitriptyline,Fluoxetine in the Treatment of Depression
下载PDF
导出
摘要 目的探讨文拉法辛与阿米替林、氟西汀治疗抑郁症的疗效和不良反应。方法将120例抑郁症患者随机分为文拉法辛组、阿米替林组和氟西汀组,分别给予文拉法辛文拉法辛50~200mg/d、阿米替林50~250mg/d以及氟西汀10~40mg/d治疗,观察6周,采用汉密尔顿抑郁量表和汉密尔顿焦虑量表评分以及副反应量表评定疗效和不良反应。结果文拉法辛组疗效与阿米替林组、氟西汀组比较差异无统计学意义(P>0.05),文拉法辛抗焦虑作用明显优于阿米替林和氟西汀组(P<0.01),文拉法辛组的不良反应和TESS评分和其他两组相比较,均有显著性差异(P<0.01)。结论文拉法辛治疗抑郁症疗效好,起效快,不良反应轻微。 Objective To explore the efficacy and side effects of the venlafaxine, amitriptyline and fluoxetine in the treatment of depression. Methods 120 Cases of depression were randomly divided into three groups, venlafaxine group were given venlafaxine 50-200mg/d and amitriptyline group were given amitriptyline 50-250mg/d as well as fluoxetine group,were given fluoxetine 10-40mg/d, after six weeks,using the Hamilton Depression Scale and Hamilton Anxiety Scale score and vice Scale to assess the efficacy and side effects. Results The difference of the efficacy between the venlafaxine group and amitriptyline group, fluoxetine group was not significant (P 〉 0.05 ), the anti-anxiety effects of venlafaxine were superior to those of fluoxetine and amitriptyline (P 〈 0.01 ), the adverse reactions and TESS score were significant difference between the venlafaxine group and the other two groups (P 〈0.01). Conclusion Venlafaxine is effective, with fast onset of action and minor adverse reactions in treatment of depression.
作者 张强
出处 《中国现代医生》 2008年第34期31-32,34,共3页 China Modern Doctor
关键词 文拉法辛 阿米替林 氟西汀 抑郁症 对照研究 Venlafaxine Amitriptyline fluoxetine Depression Control study
  • 相关文献

参考文献6

二级参考文献21

  • 1王方国,陈慧芹.文拉法辛与氯丙咪嗪治疗抑郁症对照研究[J].临床精神医学杂志,2003,13(4):230-230. 被引量:16
  • 2兰志银.抗抑郁药 文拉法新(Venlafaxine Hydrochloride)[J].国外医药(合成药.生化药.制剂分册),1996,17(4):237-240. 被引量:25
  • 3姚芳传主编.情感性精神障碍[M].长沙:湖南科学技术出版社,1999.229-231.
  • 4Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am, 1996, 19:179-200.
  • 5中华医学会精神科学会.中国精神障碍分类与诊断标准第3版(CCMD-3)[M].济南:山东科学技术出版社,2001.87-89.
  • 6Smith D, Dempster C, Glanville J, et al. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry, 2002, 180:396-404.
  • 7Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry, 2001, 178:234-241.
  • 8Stahl SM, Entsuah R, Rudolph RL.Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry, 2002, 52:1166-1174.
  • 9Kaplan EM. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study. Clin Ther, 2002, 24:1194-1200.
  • 10Judge R, Once - daily venlafaxine extended release(XR) vs. fluoxetine for the treatment of depression [ J ]. J Clin Psychiatry, 2001,62 (11) :888 -893.

共引文献120

同被引文献6

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部